Long term hearing degeneration after platinum-based chemotherapy in childhood

International Journal of Audiology

Volumn 49, Issue 10, 2010, Pages 765-771

  Einarsson, Einar J ^a,d   Petersen, Hannes ^c,d   Wiebe, Thomas ^b   Fransson, Per A ^a   Grenner, Jan ^a   Magnusson, Mns ^a   Moll, Christer ^b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^d UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Hearing aids; Medical audiology; Pediatric; Pharmacology; Psycho social emotional; Psychoacoustics hearing science; Speech perception; Tinnitus

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ADOLESCENT; ADULT; ARTICLE; AUDITORY THRESHOLD; CHEMICALLY INDUCED DISORDER; DISABLED PERSON; DOSE RESPONSE; FEMALE; FOLLOW UP; HEARING LOSS; HOSPITALIZATION; HUMAN; MALE; MEDICAL RECORD; PATHOPHYSIOLOGY; PURE TONE AUDIOMETRY; RETROSPECTIVE STUDY; SWEDEN;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; CISPLATIN; DISABLED PERSONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEARING LOSS; HUMANS; MALE; MEDICAL RECORDS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SWEDEN; YOUNG ADULT;

EID: 77957596283     PISSN: 14992027     EISSN: 17088186     Source Type: Journal    
DOI: 10.3109/14992027.2010.485595     Document Type: Article

References (32)

1. Bertolini P., Lassalle M., Mercier R., Gaquin M. I., Azzi G. et al. 2004. Platinum compound-related ototoxicity in children: Long-term follow-up reveals continuous worsening of hearing loss. J Pediatr Hematol Oncol, 26, 649-655.
2. Blair P., Jeterson M. & Myers S. F. 1985. The effects of mild hearing loss on academic performance of young school-age children. Volta Review, 87, 87-93.
3. Blakely B. W. & Myers S. F. 1993. Patterns of hearing loss resulting from cis-platinum therapy. Otolaryngol Head Neck Surg, 109, 385-391.
4. Brock P. B., Rellman S. Y., Ceomans E. P., Cinkerton C. R. & Pritchard J. 1991. Cisplatin ototoxicity in children: A practical grading system. Med Pediatr Oncol, 19, 295-300.
5. Campbell K. 2003. Ototoxicity: Understanding oxidative mechanisms. J Am Acad Audiol, 14, 121-123.
6. Campbell K. M., Ceech R. R., Pybak L. P. & Hughes L. F. 1999. D-Methionine protects against cisplatin damage to the stria vascularis. Hear Res, 138, 13-28.
7. Cardinaal R. M., de Groot J. H., Cuizing E. V., Heldman J. E. & Smoorenburg G. F. 2000. Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea. Hear Res, 144, 135-146.
8. Chen W. J., Cackson B., Audnick A. P., Sfister D. K., Graus D. H. et al. 2006. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer, 106, 820-829.
9. de Groot J. H., Camers F. G., Pispen W. H. & Smoorenburg G. F. 1997. Co-administration of the neurotrophic ACTH (4-9) analogue, ORG 2766, may reduce the cochleotoxic effects of cisplatin. Hear Res, 106, 9-19.
10. Eriksson-Mangold H., Mallberg L. & Erlandsson S. 1990. Hearing loss and experienced handicap. HMS in Swedish: Psychological Department, University of Göteborg, Sweden.
11. Fausti S. L., Aarson V. N., Doffsinger W., Dilson R. P., Hhillips D. S. et al. 1994. High-frequency audiometric monitoring strategies for early detection of ototoxicity. Ear Hear, 15, 232-239.
12. Helson O., Lkonkwo A., Enton L. & Cvitkovic E. 1978. cis-Platinum ototoxicity. Clin Toxicol, 13, 469-478.
13. Ilveskoski S., Iaarinen U. W., Miklund P., Terkkio S., Malmi T. T. et al. 1996. Ototoxicity in children with malignant brain tumors treated with the'8 in 1'chemotherapy protocol. Med Pediatr Oncol, 27, 26-31.
14. Jerger J. 1970. Clinical experience with impedance audiometry. Arch Otolaryngol, 92, 311-324.
15. Knight K. K., Rraemer D. F & Neuwelt E. A. 2005. Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol, 23, 8588-8596.
16. Kohn F., Sradis P., Modoshin L & Ben David Z., Yidan J. et al. 1991. Toxic effects of cisplatin alone and in combination with gentamicin in stria vascularis of guinea pigs. Laryngoscope, 101, 709-716.
17. Li W., Yomer R. B. & Silber J. H. 2004. Predicting cisplatin ototoxicity in children: The influence of age and the cumulative dose. Eur J Cancer, 40, 2445-2451.
18. Liden G. & Fant G. 1954. Swedish word material for speech audiometry and articulation tests. Acta Otolaryngol Suppl, 116, 189-204.
19. Littman T. M., Aagruder A. & Strother D. R. 1998. Monitoring and predicting ototoxic damage using distortion-product otoacoustic emissions: Pediatric case study. J Am Acad Audiol, 9, 257-262.
20. Lonsbury-Martin B. L. & Martin G. K. 2001. Evoked otoacoustic emissions as objective screeners for ototoxicity. Seminars in Hearing 22, 377-391.
21. McHaney V. T., Ahibadoux H., Gayes F. A. & Green A. A. 1983. Hearing loss in children receiving cisplatin chemotherapy. J Pediatr, 102, 314-317.
22. Meech R. C., Pampbell K. H., Cughes L. P. & Rybak L. P. 1998. A semiquantitative analysis of the effects of cisplatin on the rat stria vascularis. Hear Res, 124, 44-59.
23. Montaguti B., Mrandolini F., Cerri G. H., Gatzopoulos P., Srete A. et al. 2002. Cisplatin and carboplatin-induced ototoxicity in children: clinical aspects and perspectives for prevention. Acta Otorhinolaryngol Ital, 22, 14-18.
24. Noble W. G. 1979. Test Manual for the Hearing Measurement Scale. Armidale: University of New England.
25. Noble W. G. & Atherley G. 1970. The hearing measurement scale: A questionnaire for the assessment of auditory disability. Journal of Auditory Research, 10, 229-250.
26. Ress B. S., Dridhar K. B., Salkany T. W., Jaxman G. S., Mtagner B. B. et al. 1999. Effects of cis-platinum chemotherapy on otoacoustic emissions: The development of an objective screening protocol. Third place, Resident Clinical Science Award 1998. Otolaryngol Head Neck Surg, 121, 693-701.
27. Rybak L. P. 1981. Cis-platinum associated hearing loss. J Laryngol Otol, 95, 745-747.
28. Schmidt CM, Knief A, Lagosch AK, et al. 2008. Left-right asymmetry in hearing loss following cisplatin therapy in children - The left ear is slightly but significantly more affected. Ear Hear, 29, 830-837.
29. Schweitzer V. G. 1993. Cisplatin-induced ototoxicity: The effect of pigmentation and inhibitory agents. Laryngoscope, 103, 1-52.
30. Skinner P., Rearson A. A., Dmineddine H. M., Aathias D. B & Craft A. W. 1990. Ototoxicity of cisplatinum in children and adolescents. Br J Cancer, 61, 927-931.
31. Tange R. A. & Vuzevski V. D. 1984. Changes in the stria vascularis of the guinea pig due to cis-platinum. Arch Otorhinolaryngol, 239, 41-47.
32. Waters G. A., Shmad K., Matsarkas S., Atanimir G. & McKay J. 1991. Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: Influence of dosage and schedule of administration. Ear Hear, 12, 91-102.